Latest papers

Mixed Plasmodium falciparum and Plasmodium vivax Malaria in Orthotopic Liver Transplant Recipient

[Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects on gametocytic development]

MCC 'tardy' as couple suffer Mefliam 'nightmare'.

Influence of chitosan crosslinking on bitterness of mefloquine hydrochloride microparticles using central composite design.

Epileptogenic potential of mefloquine chemoprophylaxis: a pathogenic hypothesis.

Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children.

Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria.

Swedish traveller with Plasmodium knowlesi malaria after visiting Malaysian Borneo.

Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.

Mefloquine has more adverse effects than other drugs for malaria prophylaxis.

The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria.

[Case report: two imported Plasmodium falciparum cases].

Well-tolerated chemoprophylaxis uniformly prevented Swedish soldiers from Plasmodium falciparum malaria in Liberia, 2004-2006.

Blockade by mefloquine of intercellular electrical coupling between vascular endothelial cells in the guinea-pig mesenteric arteries.

Lack of multiple copies of pfmdr1 gene in Papua New Guinea.

Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate.

Molecular surveillance for multidrug-resistant Plasmodium falciparum, Cambodia.

Protection of retinal cells from ischemia by a novel gap junction inhibitor

P2X7 receptor-Pannexin1 complex: pharmacology and signaling.

Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice.